IN VITRO ANTIBACTERIAL ACTIVITY OF AQUEOUS EXTRACT OF CRANBERRY (VACCINIUM MACROCARPON) AGAINST E. COLI ISOLATED FROM URINARY TRACT INFECTION
Downloads
The present study was carried out to investigate in-vitro antibacterial activity of aqueous extract of Cranberry (Vaccinium macrocarpon) fruit against Escherichia coli isolated from urinary tract infection. The present study included two experiment; the first one is isolate and identify of E. coli; the second experiment include study in-vitro antibacterial activity of aqueous extract of Cranberry, consisting two steps, the first step involved collection of Cranberry fruit then they were identified and then squeezed by an electric mixer to obtain the aqueous extract. The fruit extract then dried. The second step was to study the in vitro antibacterial activity of Cranberry aqueous extract including minimum inhibitory concentration (MIC) against E. coli used as reference antibiotics. The yielding percentage of Cranberry (Vaccinium macrocarpon) fruit extract was (30%). The in-vitro antibacterial study showed the Cranberry aqueous extract was more effective than Gentamicin against E.coli, this organism was quite resistant to Ciprofloxacin. It could be concluded however that Cranberry aqueous extract was more effective in comparison with the standard antibacterial agent, and that the antibacterial activity of Cranberry aqueous extracts against urinary tract infection may be attributed to its essential particularly the important phenolic compound (Proanthocyanidin).
. Ahmed, M.; Mumtaz, S. and Iqbal, J. (1997). Urinary tract infection: Prevalent organism and their sensitivity pattern in catheterized patients. Pak. J. Med. Res., 36: 136-139.
. Asghari, G.; Nourallahi, H.; Havaie, S.A. and Issa, L. (2006). Antimicrobial activity of Otostegia persica Boiss Extracts. Res. Pharm. Sci., 1: 53–58.
. Bahrani-Mougeot, F.K.; Buckles, E.L.; Lockatell, C.V.; Hebel, J.R.; Johnson, D.E.; Tang, C.M. and Donnenberg, M.S. (2002). Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol. Microbiol., 45: 1079– 1093.
. Brisse, S.; Milatovic, D.; Fluit, A.C. and Verhoef, J. (1999). Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, oxifloxacin and trofloxacin against K.pneumoniae, K.oxytoca, Enterobacter aerogenes clinical isolates with alteration in Gyr A and Par C proteins. J. A. Antimicrob. gents Chemother., 43:2051-5.
. Cibele B.; Morton B.; Brown, M. and Busscher, B.F. (2011).Cranberry juice fails to prevent recurrent urinary tract infection: Results –controlled trail. Clin. Infect. Dis., 52(1): 23-30.
. Cimolai, N. and Cimolai, T. (2007). The cranberry and the urinary tract. Eur. J. Clin.
. Microbiol., 26: 767-776.
. Cox, P.A. and Balick, M.J. (1994). The ethnobotanical approach to drug discovery. Sci.
. Am. 270: 60-65.
. Deborah, S.; Blumenthal, M. and Ferrier, G.K. (2010). Total sales of herbal supplements in United States show steady growth. Herbal Gram 71: 64-66 Badaruddin, A.M. (2007). Predominant and common cause of urinary tract infection in Sukkur city. Clin. Infect. Dis., 29: 745-746.
. Fehri, B.( 1994).J Pharm Belg , Mar-Apr; 49(2):101-108.
. Fluit, A.C.; Visser, M.R. and Schmitz, F.J. (2001). Molecular detection of antimicrobial resistance. Clin. Microbiol. Rev., 41:836-71.
. Goossens, H.; Ferech, M.; Vander Stichele, R. and Elseviers, M. (2005). Outpatient
. antibiotic use in Europe and association with resistance: a cross-national database study. Lancet, 365 (9459): 579–587.
. Grove, D.C. and Randall, W.A. (1955). Assay methods of antibiotic monograph.
. Medical Encyclopedia, No.2 Inc. New York. USA. Pp: 24-55.
. Gunther, N.W.; Lockatell, V.; Johnson, D.E. and Mobley, H.L. (2001). In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection. Infect. Immun., 69: 2838– 2846.
. Hirsch, A.C. and Lundquist, L.M. (2009). Ciprofloxacin-induced hepatotoxicity resolved with levofloxacin: A case report and a review of the literature. Hospital Pharmacy. 44(11):978–983.
. Iroha, I.R.; Adikwu, M.U.; Esimone, C.O.; Aibinu, I. and Amadi, E.S. (2009). Extended spectrum Beta-Lactamase (ESBL) in E.coli isolated from a tertiary hospital in Enugu State, Nigeria. Pak. J. Med. Sci., 25(2): 279- 282.
. Iwu, M.W.; Duncan, A.R. and Okunji, C.O. (1999). New antimicrobials of plant origin. In: Janick J. ed. Perspectives on New Crops and New Uses. Alexandria, VA: ASHS Press, Pp. 457-462
. Jass, J. and Reid, G. (2009). Effect of cranberry drink on bacterial adhesion in vitro and vaginal microbiota in healthy females. Can. J. Urol., 16: 4901- 4907.
. Joseph, W.B. (2007).Urinary tract infection: selfreported incidence and associated costs. Ann Epidemiol , 10: 509-15.
. Kavanagh, F. (1972). "Analytical Microbiology". Vol.: II, Academic Press, New York, and London, P:11.
. Klein, M.A. (2005). Cranberry (Vaccinium macrocarpon) Aiton. In: Encyclopedia of Dietary Supplements; Coates, P., Blackman, M.R., Cragg, G., Levine, M., Moss, J., White, J., Eds.; Marcel Dekker: New York, Pp: 143-149.
. Kunin, C. (1997). "Urinary Tract Infections". 5th Ed. Baltimore: Williams and Wilkins, Pp: 301-304.
. Mohammad, R. and Kambiz, D. (2010). In vitro activity of cranberry extract against etiological agents of urinary tract infections. Afr. J. Pharm. Pharmacol., 4(5): 286- 288,
. Mulvey, M.A. (2002). Adhesion and entry of uropathogenic Escherichia coli. Cell Microbiol., 4(5):257–271.
. NCCLS, (2000). National Committee for Clinical Laboratory Standards. Approved Standard M7-A5: Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically, 5th Ed. Pp: 4-9.
. Okwu, D.E. and Igara, E.C. (2009). Isolation, characterization and antibacterial activity of alkaloid from Datura metel Linn leaves. Afr. J. Pharm. Pharmacol., 3: 277-281.
. Quinn, P.J.; Markey, B.K.; Carter, M.E.; Donnelly, W.J. and Leonard, F.C. (2004). "Veterinary Microbiology and Microbial Diseases Textbook". Printed and bound in Great Britain by International Ltd. Mosby, London, Padstow-Cornwall. Pp: 118-126.
. Ronald, A. (2003). The etiology of urinary tract infection: Traditional and emerging pathogens. Dis. Mon. 49(2): 71–82.
. Sakran, W.; Miron, D.; Halevy, R.; Colodner, R.; Smolkin, V and Koren, A. (2003). Community acquired urinary tract infection among hospitalized children in northern Israel: Pathogens, susceptibility patterns and urinary tract anomalies. Harefuah, 142(4): 249–252.
. Sharma, A. and Patel, V.K. (2009). In vitro screening of the antibacterial activity and identification of bioactive compounds from plants against selected urinary tract infections. Cochrane Database Syst. Rev. 12: 2-4
. Todar, K. (2007). "The Mechanisms of Bacterial Pathogenicity". Todar’s Online Textbook of Bacteriology. 2nd Ed., Wisconsin University, USA. Pp: 6-8.
. Wilson, M.L. and Gaido, L. (2004). Laboratory diagnosis of urinary tract infections in adult patients. Clin. Infect. Dis., 38(8): 1150–1158.
Copyright (c) 2024 Ruqayyah Hussein Kazim Ghulam, Milad Munther Zahid Baniya, Adyan abd Al_khalq aziz nema, Messad Hammad Kadhim Edam, Muslim Hakim Nahi Thaher
This work is licensed under a Creative Commons Attribution 4.0 International License.
